Global Small Molecule Drug Discovery Market Segments 2024, Forecast To 2033
5 Mar, 2024
The small molecule drug discovery market has demonstrated strong growth, moving from $57.41 billion in 2023 to $63.15 billion in 2024, with a CAGR of 10.0%. This growth is attributed to drug repurposing initiatives and increased investment in R&D. Anticipated rapid growth projects the market size to reach $95.63 billion in 2028, sustaining a CAGR of 10.9%. Key trends include fragment-based drug discovery and the integration of artificial intelligence.
Global Small Molecule Drug Discovery Market Key Driver
The small molecule drug discovery market is expanding due to the rising incidence of chronic diseases. The NIH predicts a 99.5% increase in people aged 50 and older with at least one chronic illness in the U.S. by 2050. This upsurge in chronic diseases is a major driver propelling the growth of the small molecule drug discovery market.
Get A Free Sample Of The Global Small Molecule Drug Discovery Market ReportGlobal Small Molecule Drug Discovery Market Segments
The small molecule drug discovery market covered in this report is segmented –
1) By Drug Type: Small Molecule Drugs, Biologic Drugs
2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others
3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others
4) By Process/Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization
5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the small molecule drug discovery market in 2023. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Small Molecule Drug Discovery Industry Players
Pfizer Inc.; GlaxoSmithKline plc; AstraZeneca; Boehringer Ingelheim International GmbH; Bristol-Myers Squibb Company; Johnson & Johnson; Gilead Sciences Inc.; Merck KGaA; Novartis AG; 21st Century Therapeutics Inc.; 4SC AG; Teva Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited; Immunocure Inc.; Labcorp Drug Development; ICON Public Limited Company; Charles River Laboratories; Aluda Pharmaceuticals; CelerisTx; Clinuvel Pharmaceuticals; Corcept Therapeutics; Doloromics; Edison Oncology; Escend Pharmaceuticals; Terray Therapeutics; Apollomics; Astex Pharmaceuticals; Surface Ophthalmics; Pardes Biosciences; Xynomic Pharmaceuticals; AfaSci; Zevra Therapeutics; Saniona; UNION therapeutics; Tetra Pharm Technologies; Pharmacosmos; Allarity Therapeutics; Xellia Pharmaceuticals; Cyteir Therapeutics; BigHat Biosciences
Get The Full Global Small Molecule Drug Discovery Market Report
AIOps Small Molecule Drug Discovery Market Overview
Small molecule drug discovery refers to discovering a medicine with a low molecular weight that may easily penetrate cells. Small-molecule drugs are used to cure or prevent diseases.
Small Molecule Drug Discovery Global Market Report 2023 provides data on the global small molecule drug discovery market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The small molecule drug discovery market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.